• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-135a通过直接靶向人类胆囊癌中的极低密度脂蛋白受体发挥假定的肿瘤抑制作用。

MicroRNA-135a acts as a putative tumor suppressor by directly targeting very low density lipoprotein receptor in human gallbladder cancer.

作者信息

Zhou Huading, Guo Weijie, Zhao Yingjun, Wang Yifei, Zha Ruopeng, Ding Jie, Liang Linhui, Yang Guanghua, Chen Zongyou, Ma Baojin, Yin Baobing

机构信息

Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.

出版信息

Cancer Sci. 2014 Aug;105(8):956-65. doi: 10.1111/cas.12463.

DOI:10.1111/cas.12463
PMID:24903309
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4317855/
Abstract

The precise functions and mechanisms of microRNAs (miR) in gallbladder cancer (GBC) remain elusive. In this study, we found that miR-135a-5p expression is often dampened and correlated with neoplasm histologic grade in GBC. MicroRNA-135a-5p introduction clearly inhibited GBC cell proliferation in vitro and in vivo. Moreover, very low density lipoprotein receptor (VLDLR), which is often upregulated in GBC tissues, was identified as a direct functional target of miR-135a-5p. Furthermore, the p38 MAPK pathway was proven to be involved in miR-135a-VLDLR downstream signaling. Together, these results suggested that the miR-135a-VLDLR-p38 axis may contribute to GBC cell proliferation.

摘要

微小RNA(miR)在胆囊癌(GBC)中的精确功能和机制仍不清楚。在本研究中,我们发现miR-135a-5p的表达常常受到抑制,且与GBC的肿瘤组织学分级相关。引入MicroRNA-135a-5p明显抑制了GBC细胞在体外和体内的增殖。此外,在GBC组织中经常上调的极低密度脂蛋白受体(VLDLR)被确定为miR-135a-5p的直接功能靶点。此外,p38丝裂原活化蛋白激酶(MAPK)通路被证明参与了miR-135a-VLDLR的下游信号传导。总之,这些结果表明miR-135a-VLDLR-p38轴可能促进GBC细胞增殖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dac/4317855/aa975d764fd7/cas0105-0956-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dac/4317855/edfb6ab173dc/cas0105-0956-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dac/4317855/b28603c7e467/cas0105-0956-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dac/4317855/955cb5cf334f/cas0105-0956-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dac/4317855/ec2f02f7aa27/cas0105-0956-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dac/4317855/aa975d764fd7/cas0105-0956-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dac/4317855/edfb6ab173dc/cas0105-0956-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dac/4317855/b28603c7e467/cas0105-0956-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dac/4317855/955cb5cf334f/cas0105-0956-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dac/4317855/ec2f02f7aa27/cas0105-0956-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dac/4317855/aa975d764fd7/cas0105-0956-f5.jpg

相似文献

1
MicroRNA-135a acts as a putative tumor suppressor by directly targeting very low density lipoprotein receptor in human gallbladder cancer.微小RNA-135a通过直接靶向人类胆囊癌中的极低密度脂蛋白受体发挥假定的肿瘤抑制作用。
Cancer Sci. 2014 Aug;105(8):956-65. doi: 10.1111/cas.12463.
2
Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.长链非编码RNA H19通过调控miR-194-5p靶向AKT2促进胆囊癌细胞增殖。
Tumour Biol. 2016 Jul;37(7):9721-30. doi: 10.1007/s13277-016-4852-1. Epub 2016 Jan 23.
3
miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer.miR-1和miR-145在胆囊癌中作为肿瘤抑制性微小RNA发挥作用。
Int J Clin Exp Pathol. 2014 Apr 15;7(5):1849-67. eCollection 2014.
4
Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4.过表达 microRNA-136 通过抑制 MAP2K4 抑制 JNK 信号通路在胆囊癌中作为抑癌基因发挥作用。
Am J Physiol Gastrointest Liver Physiol. 2019 Nov 1;317(5):G670-G681. doi: 10.1152/ajpgi.00055.2019. Epub 2019 Aug 1.
5
MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7.MicroRNA-30a-5p 通过靶向 E2F7 抑制胆囊癌细胞增殖、迁移和转移。
Cell Death Dis. 2018 Mar 14;9(3):410. doi: 10.1038/s41419-018-0444-x.
6
MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway.微小RNA-29c-5p通过直接靶向CPEB4并抑制丝裂原活化蛋白激酶(MAPK)途径来抑制胆囊癌进展。
Cell Death Differ. 2017 Mar;24(3):445-457. doi: 10.1038/cdd.2016.146. Epub 2017 Jan 6.
7
MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma.miR-139-5p 与胆囊癌不良预后相关,通过抑制 PKM2 来调节糖酵解。
Cell Prolif. 2018 Dec;51(6):e12510. doi: 10.1111/cpr.12510. Epub 2018 Aug 13.
8
The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer.微小RNA miR-33a通过与胆囊癌中的Twist结合来抑制白细胞介素-6诱导的肿瘤进展。
Oncotarget. 2016 Nov 29;7(48):78640-78652. doi: 10.18632/oncotarget.12693.
9
MicroRNA-135a-3p is downregulated and serves as a tumour suppressor in ovarian cancer by targeting CCR2.微小 RNA-135a-3p 在卵巢癌中下调并作为肿瘤抑制因子通过靶向 CCR2 发挥作用。
Biomed Pharmacother. 2018 Nov;107:712-720. doi: 10.1016/j.biopha.2018.08.044. Epub 2018 Aug 20.
10
Therapeutic effects of long-circulating miR-135a-containing cationic immunoliposomes against gallbladder carcinoma.长循环 miR-135a 阳离子免疫脂质体对胆囊癌的治疗作用。
Sci Rep. 2017 Jul 20;7(1):5982. doi: 10.1038/s41598-017-06234-8.

引用本文的文献

1
MicroRNA-34a-5p: A pivotal therapeutic target in gallbladder cancer.微小RNA-34a-5p:胆囊癌中的关键治疗靶点。
Mol Ther Oncol. 2024 Feb 8;32(1):200765. doi: 10.1016/j.omton.2024.200765. eCollection 2024 Mar 21.
2
IncRNA AC004943.2 regulates miR-135a-5p and PTK2/P13K axis to promote laryngeal squamous cell carcinoma progression.长链非编码RNA AC004943.2通过调控miR-135a-5p和PTK2/PI3K轴促进喉鳞状细胞癌进展。
J Cell Commun Signal. 2024 Feb 9;18(1):e12016. doi: 10.1002/ccs3.12016. eCollection 2024 Mar.
3
Genetic Factors and MicroRNAs in the Development of Gallbladder Cancer: The Prospective Clinical Targets.

本文引用的文献

1
miR-135a/b modulate cisplatin resistance of human lung cancer cell line by targeting MCL1.miR-135a/b 通过靶向 MCL1 调节人肺癌细胞系对顺铂的耐药性。
Pathol Oncol Res. 2013 Oct;19(4):677-83. doi: 10.1007/s12253-013-9630-4. Epub 2013 May 3.
2
Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma.抑癌 microRNA-135a 通过靶向肾细胞癌中的 c-MYC 癌基因抑制癌细胞增殖。
Cancer Sci. 2013 Mar;104(3):304-12. doi: 10.1111/cas.12072. Epub 2012 Dec 29.
3
MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation.
胆囊癌发生中的遗传因素与微小RNA:潜在的临床靶点
Curr Drug Targets. 2024;25(6):375-387. doi: 10.2174/0113894501182288240319074330.
4
miR-497 Regulates through the Pathway to Participate in Fatty Acid Synthesis in Bovine Mammary Epithelial Cells.miR-497 通过 途径调节参与牛乳腺上皮细胞的脂肪酸合成。
Genes (Basel). 2023 Jun 5;14(6):1224. doi: 10.3390/genes14061224.
5
The inverse association between fasting blood glucose and the occurrence of gallbladder cancer in type 2 diabetes mellitus patients: a case-control study.2型糖尿病患者空腹血糖与胆囊癌发生之间的负相关:一项病例对照研究。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10387-10398. doi: 10.1007/s00432-023-04944-3. Epub 2023 Jun 5.
6
analysis to identify novel ceRNA regulatory axes associated with gallbladder cancer.分析以鉴定与胆囊癌相关的新型ceRNA调控轴。
Front Genet. 2023 Feb 16;14:1107614. doi: 10.3389/fgene.2023.1107614. eCollection 2023.
7
Cancer and Alzheimer's Inverse Correlation: an Immunogenetic Analysis.癌症与老年痴呆症呈负相关:免疫遗传学分析。
Mol Neurobiol. 2023 Jun;60(6):3086-3099. doi: 10.1007/s12035-023-03260-8. Epub 2023 Feb 16.
8
VLDLR disturbs quiescence of breast cancer stem cells in a ligand-independent function.极低密度脂蛋白受体(VLDLR)通过非配体依赖性功能扰乱乳腺癌干细胞的静止状态。
Front Oncol. 2022 Dec 7;12:887035. doi: 10.3389/fonc.2022.887035. eCollection 2022.
9
Elevated serum triglyceride levels may be a key independent predicting factor for gallbladder cancer risk in gallbladder stone disease patients: a case-control study.血清甘油三酯水平升高可能是胆囊结石病患者胆囊癌风险的一个关键独立预测因素:一项病例对照研究。
BMC Endocr Disord. 2022 Nov 8;22(1):270. doi: 10.1186/s12902-022-01189-y.
10
Effects of Long Noncoding RNA HOXA-AS2 on the Proliferation and Migration of Gallbladder Cancer Cells.长链非编码RNA HOXA-AS2对胆囊癌细胞增殖和迁移的影响
J Oncol. 2022 Oct 17;2022:6051512. doi: 10.1155/2022/6051512. eCollection 2022.
miR-135a 靶向 JAK2 并抑制胃癌细胞增殖。
Cancer Biol Ther. 2012 Mar;13(5):281-8. doi: 10.4161/cbt.18943. Epub 2012 Mar 1.
4
MiR-135a functions as a selective killer of malignant glioma.miR-135a 作为恶性神经胶质瘤的选择性杀伤剂发挥作用。
Oncogene. 2012 Aug 23;31(34):3866-74. doi: 10.1038/onc.2011.551. Epub 2011 Dec 5.
5
miR-200c regulates FGFR-dependent epithelial proliferation via Vldlr during submandibular gland branching morphogenesis.miR-200c 通过 Vldlr 调控 FGFR 依赖性上皮增殖,参与下颌下腺分支形态发生。
Development. 2012 Jan;139(1):191-202. doi: 10.1242/dev.070151. Epub 2011 Nov 24.
6
miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo.miR-135a 在肿瘤细胞的体内外均有助于紫杉醇耐药。
Oncogene. 2011 Oct 27;30(43):4386-98. doi: 10.1038/onc.2011.148. Epub 2011 May 9.
7
The role of Sp1 and Sp3 in normal and cancer cell biology.Sp1 和 Sp3 在正常细胞和癌细胞生物学中的作用。
Ann Anat. 2010 Sep 20;192(5):275-83. doi: 10.1016/j.aanat.2010.07.010. Epub 2010 Aug 6.
8
Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma.miR-135a对JAK2的调控:在经典型霍奇金淋巴瘤中的预后影响
Blood. 2009 Oct 1;114(14):2945-51. doi: 10.1182/blood-2009-02-204842. Epub 2009 Aug 7.
9
MicroRNAs: target recognition and regulatory functions.微小RNA:靶标识别与调控功能
Cell. 2009 Jan 23;136(2):215-33. doi: 10.1016/j.cell.2009.01.002.
10
Most mammalian mRNAs are conserved targets of microRNAs.大多数哺乳动物的信使核糖核酸是微小核糖核酸的保守靶标。
Genome Res. 2009 Jan;19(1):92-105. doi: 10.1101/gr.082701.108. Epub 2008 Oct 27.